PapersFlow Research Brief

Health Sciences · Medicine

Microscopic Colitis
Research Guide

What is Microscopic Colitis?

Microscopic colitis is a type of inflammatory bowel disease characterized by chronic watery diarrhea and normal endoscopic appearance of the colon, with microscopic inflammation revealed by biopsy, including subtypes collagenous colitis and lymphocytic colitis.

This field encompasses 30,193 papers on the epidemiology, pathophysiology, diagnosis, and treatment of microscopic colitis. Research covers budesonide treatment, histological features, drug-induced colitis, and associations with other gastrointestinal disorders. Studies link proton pump inhibitors and medications to its development.

Topic Hierarchy

100%
graph TD D["Health Sciences"] F["Medicine"] S["Epidemiology"] T["Microscopic Colitis"] D --> F F --> S S --> T style T fill:#DC5238,stroke:#c4452e,stroke-width:2px
Scroll to zoom • Drag to pan
30.2K
Papers
N/A
5yr Growth
236.5K
Total Citations

Research Sub-Topics

Why It Matters

Microscopic colitis affects chronic disease management in gastroenterology, with research distinguishing it from inflammatory bowel disease subtypes like Crohn's disease and ulcerative colitis. Ng et al. (2017) in "Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies" report rising global incidence of inflammatory bowel disease, relevant to microscopic colitis epidemiology (5648 citations). Molodecky et al. (2011) in "Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review" document increasing prevalence, aiding diagnosis differentiation from ulcerative colitis treated by infliximab as shown by Rutgeerts et al. (2005) (4746 citations). These insights guide treatment strategies like budesonide for collagenous and lymphocytic colitis.

Reading Guide

Where to Start

"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies" by Ng et al. (2017), as it offers foundational epidemiology relevant to microscopic colitis within inflammatory bowel disease.

Key Papers Explained

Ng et al. (2017) in "Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies" establishes global trends building on Molodecky et al. (2011) "Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review". Frank et al. (2007) "Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases" examines microbiota shifts applicable to microscopic colitis pathophysiology. Sokol et al. (2008) identifies anti-inflammatory bacteria like Faecalibacterium prausnitzii in Crohn's contexts, extending to colitis subtypes.

Paper Timeline

100%
graph LR P0["Infliximab for Induction and Mai...
2005 · 3.8K cites"] P1["Toward an Integrated Clinical, M...
2005 · 3.3K cites"] P2["Molecular-phylogenetic character...
2007 · 4.5K cites"] P3["Faecalibacterium prausnitzii<...
2008 · 4.2K cites"] P4["Increasing Incidence and Prevale...
2011 · 4.7K cites"] P5["Ulcerative colitis
2016 · 3.2K cites"] P6["Worldwide incidence and prevalen...
2017 · 5.6K cites"] P0 --> P1 P1 --> P2 P2 --> P3 P3 --> P4 P4 --> P5 P5 --> P6 style P6 fill:#DC5238,stroke:#c4452e,stroke-width:2px
Scroll to zoom • Drag to pan

Most-cited paper highlighted in red. Papers ordered chronologically.

Advanced Directions

Current focus remains on budesonide treatment efficacy, drug-induced cases from proton pump inhibitors, and histological differentiation in collagenous and lymphocytic colitis, as no recent preprints or news available.

Papers at a Glance

# Paper Year Venue Citations Open Access
1 Worldwide incidence and prevalence of inflammatory bowel disea... 2017 The Lancet 5.6K
2 Increasing Incidence and Prevalence of the Inflammatory Bowel ... 2011 Gastroenterology 4.7K
3 Molecular-phylogenetic characterization of microbial community... 2007 Proceedings of the Nat... 4.5K
4 <i>Faecalibacterium prausnitzii</i> is an anti-inflammatory co... 2008 Proceedings of the Nat... 4.2K
5 Infliximab for Induction and Maintenance Therapy for Ulcerativ... 2005 New England Journal of... 3.8K
6 Toward an Integrated Clinical, Molecular and Serological Class... 2005 Canadian Journal of Ga... 3.3K
7 Ulcerative colitis 2016 The Lancet 3.2K
8 Development of a Crohn's disease activity index. National Coop... 1976 PubMed 3.2K
9 Inflammatory Bowel Disease 2002 New England Journal of... 3.1K
10 Development of a Crohn's Disease Activity Index 1976 Gastroenterology 3.1K

Frequently Asked Questions

What distinguishes microscopic colitis from inflammatory bowel disease?

Microscopic colitis shows normal colon appearance on endoscopy but inflammation on biopsy, unlike Crohn's disease or ulcerative colitis which often have macroscopic lesions. It includes collagenous colitis and lymphocytic colitis subtypes. Associations exist with drug-induced cases and proton pump inhibitors.

How is budesonide used in microscopic colitis treatment?

Budesonide serves as a primary treatment for microscopic colitis, targeting inflammation in collagenous and lymphocytic forms. Research highlights its efficacy in inducing remission. It contrasts with infliximab used for ulcerative colitis as in Rutgeerts et al. (2005).

What role do proton pump inhibitors play in microscopic colitis?

Proton pump inhibitors associate with development of microscopic colitis through drug-induced mechanisms. Studies in this field examine their impact on histological features. This links to broader gastrointestinal tract disorder research.

What are the histological features of microscopic colitis?

Histological features include increased intraepithelial lymphocytes in lymphocytic colitis and collagen band in collagenous colitis. These appear normal macroscopically. Diagnosis relies on biopsy confirmation.

How does microscopic colitis relate to Crohn's disease activity indices?

While Crohn's disease uses indices like the Crohn's Disease Activity Index from Best et al. (1976), microscopic colitis diagnosis focuses on histology, not activity scores. Differentiation aids management. Ng et al. (2017) provide epidemiological context.

Open Research Questions

  • ? What are the precise pathophysiological mechanisms linking proton pump inhibitors to drug-induced microscopic colitis?
  • ? How do histological features of collagenous versus lymphocytic colitis predict treatment response to budesonide?
  • ? What epidemiological trends distinguish incidence of microscopic colitis from broader inflammatory bowel disease?
  • ? Which microbial community imbalances specifically contribute to microscopic colitis onset?

Research Microscopic Colitis with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Microscopic Colitis with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers

Curated by PapersFlow Research Team · Last updated: February 2026

Academic data sourced from OpenAlex, an open catalog of 474M+ scholarly works · Web insights powered by Exa Search

Editorial summaries on this page were generated with AI assistance and reviewed for accuracy against the source data. Paper metadata, citation counts, and publication statistics come directly from OpenAlex. All cited papers link to their original sources.